Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - betahistindihydrochlorid - tabletter - 8 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - betahistindihydrochlorid - tabletter - 16 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

biocryst ireland limited - berotralstat dihydrochloride - angioødemer, arvelige - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

dipharma arzneimittel gmbh - sapropterin dihydrochlorid - phenylketonurias - andre alimentary tract and metabolism produkter, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastiske midler - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - carcinom, ikke-småcellet lunge - antineoplastiske midler - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukæmi, myeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

laboratoires delbert - histamin dihydrochlorid - leukæmi, myeloid, akut - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). effekten af ​​ceplene er ikke fuldt ud demonstreret hos patienter ældre end 60 år.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

biomarin international limited - sapropterin dihydrochlorid - phenylketonurias - andre alimentary tract and metabolism produkter, - kuvan er indiceret til behandling af hyperphenylalaninæmi (hpa) hos voksne og pædiatriske patienter i alle aldre med phenylketonuri (pku), som har vist sig at være responsive over for sådan behandling. kuvan er også indiceret til behandling af hyperphenylalaninaemia (hpa) hos voksne og pædiatriske patienter i alle aldre med tetrahydrobiopterin (bh4) - mangel, som har vist sig at være lydhør over for en sådan behandling,.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - cetirizindihydrochlorid - filmovertrukne tabletter - 10 mg